Syneos Health and Elligo Announce Strategic Collaboration
Syneos Health, a biopharmaceutical solutions organization, including CRO services, and Elligo Health Research, a provider of clinical research services to physician practices, are entering a strategic collaboration. Syneos Health will collaborate with Elligo to pilot new ways of quickly finding patients to enlist them in clinical trial research. Elligo’s platform identifies patients for clinical trials using electronic health records and then provides their physicians with the infrastructure to conduct the research in their own practices. The collaboration will seek to build a centrally managed infrastructure and regulatory research system, which could include deploying expert staff and providing the training and regulatory guidance needed to run a trial, removing physician burden.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
